Nitric oxide signaling in vascular biology

Willerson, 2003, Endothelial dysfunction, Circulation, 108, 2060, 10.1161/01.CIR.0000099580.72044.83

Ishii, 2001, Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus, J Am Soc Nephrol, 12, 1630, 10.1681/ASN.V1281630

Eiserich, 1998, Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils, Nature, 391, 393, 10.1038/34923

Marsh, 2000, A short history of nitroglycerine and nitric oxide in pharmacology and physiology, Clin Exp Pharmacol Physiol, 27, 313, 10.1046/j.1440-1681.2000.03240.x

Ignarro, 1981, Mechanism of vascular smooth muscle relaxation by organic nitrates, NO2 ±, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates, J Pharmacol Exp Ther, 218, 739

Bennett, 1988, Effect of in vitro organic nitrate tolerance on relaxation, cyclic GMP accumulation, and guanylate cyclase activation by glyceryl trinitrate and the enantiomers of isoidide dinitrate, Circ Res, 63, 693, 10.1161/01.RES.63.4.693

Papapetropoulos, 1996, Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells, Br J Pharmacol, 117, 147, 10.1111/j.1476-5381.1996.tb15167.x

Chen, 2002, Identification of the enzymatic mechanism of nitroglycerin bioactivation, Proc Natl Acad Sci U S A, 99, 8306, 10.1073/pnas.122225199

Gow, 2002, Basal and stimulated protein S-nitrosylation in multiple cell types and tissues, J Biol Chem, 277, 9637, 10.1074/jbc.C100746200

Al-Sa’doni, 2000, S-nitrosothiols: a class of nitric oxide-donor drugs, Clin Sci (Lond), 98, 507, 10.1042/CS19990267

Patel, 2000, Biochemical aspects of the reaction of hemoglobin and NO: implications for Hb-based blood substitutes, Free Radic Biol Med, 28, 1518, 10.1016/S0891-5849(00)00259-8

McMahon, 2002, Nitric oxide in the human respiratory cycle, Nat Med, 8, 711, 10.1038/nm718

Pawloski, 2001, Export by red blood cells of nitric oxide bioactivity, Nature, 409, 622, 10.1038/35054560

Joshi, 2002, Nitric oxide is consumed, rather than conserved, by reaction with oxyhemoglobin under physiological conditions, Proc Natl Acad Sci U S A, 99, 10341, 10.1073/pnas.152149699

Jourd’heuil, 2000, Dynamic state of S-nitrosothiols in human plasma and whole blood, Free Radic Biol Med, 28, 409, 10.1016/S0891-5849(99)00257-9

Jia, 1998, The effects of S-nitrosocaptopril on renal filtration and blood pressure in rats, Eur J Pharmacol, 354, 33, 10.1016/S0014-2999(98)00424-5

Stamler, 1992, S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and anti-platelet properties on the enzyme, Proc Natl Acad Sci U S A, 89, 8087, 10.1073/pnas.89.17.8087

Morley, 1993, Nitric oxide/nucleophile complexes: a unique class of nitric oxide-based vasodilators, J Cardiovasc Pharmacol, 22, S3, 10.1097/00005344-199300221-00003

Fitzhugh, 2000, Diazeniumdiolates: pro- and antioxidant applications of the “NONOates”, Free Radic Biol Med, 28, 1463, 10.1016/S0891-5849(00)00251-3

Turko, 2002, Protein nitration in cardiovascular diseases, Pharmacol Rev, 54, 619, 10.1124/pr.54.4.619

Bian, 2003, Nitric oxide (NO)—biogeneration, regulation, and relevance to human diseases, Front Biosci, 8, d264, 10.2741/997

Willerson, 2002, Systemic and local inflammation in patients with unstable atherosclerotic plaques, Prog Cardiovasc Dis, 44, 469, 10.1053/pcad.2002.123782

Beckmann, 1994, Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry, Biol Chem Hoppe Seyler, 375, 81, 10.1515/bchm3.1994.375.2.81

Evans, 1996, Do human atherosclerotic lesions contain nitrotyrosine?, Biochem Biophys Res Commun, 226, 346, 10.1006/bbrc.1996.1359

Morton, 2003, Comparison of nitration and oxidation of tyrosine in advanced human carotid plaque proteins, Biochem J, 370, 339, 10.1042/bj20020964

Sucu, 2003, 3-Nitrotyrosine in atherosclerotic blood vessels, Clin Chem Lab Med, 41, 23, 10.1515/CCLM.2003.005

Luoma, 1998, Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins, Arterioscler Thromb Vasc Biol, 18, 157, 10.1161/01.ATV.18.2.157

Baker, 1999, Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages, Arterioscler Thromb Vasc Biol, 19, 646, 10.1161/01.ATV.19.3.646

Leeuwenburgh, 1997, Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima, J Biol Chem, 272, 1433, 10.1074/jbc.272.3.1433

Zou, 1999, Selective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerotic bovine coronary arteries, Am J Pathol, 154, 1359, 10.1016/S0002-9440(10)65390-4

Bar-Shavit, 1991, An Arg-Gly-Asp sequence within thrombin promotes endothelial cell adhesion, J Cell Biol, 112, 335, 10.1083/jcb.112.2.335

Vadseth, 2004, Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species, J Biol Chem, 279, 8226, 10.1074/jbc.M306101200

Murad, 1999, Cellular signaling with nitric oxide and cyclic GMP, Braz J Med Biol Res, 32, 1317, 10.1590/S0100-879X1999001100001

Beckman, 2002, Protein tyrosine nitration and peroxynitrite, Faseb J, 16, 1144, 10.1096/fj.02-0133lte

Souza, 1999, Factors determining the selectivity of protein tyrosine nitration, Arch Biochem Biophys, 371, 169, 10.1006/abbi.1999.1480

Sampson, 1998, Myeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide, Arch Biochem Biophys, 356, 207, 10.1006/abbi.1998.0772

Thukkani, 2003, Myeloperoxidase-derived reactive chlorinating species from human monocytes target plasmalogens in low density lipoprotein, J Biol Chem, 278, 36365, 10.1074/jbc.M305449200

Augusto, 2002, Nitrogen dioxide and carbonate radical anion: two emerging radicals in biology, Free Radic Biol Med, 32, 841, 10.1016/S0891-5849(02)00786-4

Dunford, 1995, One-electron oxidations by peroxidases, Xenobiotica, 25, 725, 10.3109/00498259509061888

Paoli, 2002, Structure-function relationships in heme-proteins, DNA Cell Biol, 21, 271, 10.1089/104454902753759690

Nelson, 1991, Reduction of the active-site iron by potent inhibitors of lipoxygenases, J Biol Chem, 266, 8225, 10.1016/S0021-9258(18)92965-0

Ponka, 1999, Cell biology of heme, Am J Med Sci, 318, 241, 10.1097/00000441-199910000-00004

Asatryan, 2003, Heme and lipid peroxides in hemoglobin-modified low-density lipoprotein mediate cell survival and adaptation to oxidative stress, Blood, 102, 1732, 10.1182/blood-2003-01-0293

Isogai, 1995, The mechanism of electron donation to molecular oxygen by phagocytic cytochrome b558, J Biol Chem, 270, 7853, 10.1074/jbc.270.14.7853

Thomas, 2002, Protein nitration is mediated by heme and free metals through Fenton-type chemistry: an alternative to the NO/O2-reaction, Proc Natl Acad Sci U S A, 99, 12691, 10.1073/pnas.202312699

Comporti, 2002, Introduction-serial review: iron and cellular redox status, Free Radic Biol Med, 32, 565, 10.1016/S0891-5849(02)00758-X

Lovstad, 1995, A kinetic study of the coupled iron-ceruloplasmin catalyzed oxidation of ascorbate in the presence of albumin, Biometals, 8, 328, 10.1007/BF00141606

Fraga, 2002, Iron toxicity and antioxidant nutrients, Toxicology, 180, 23, 10.1016/S0300-483X(02)00379-7

Viner, 1997, In vivo aging of rat skeletal muscle sarcoplasmic reticulum Ca-ATPase, Biochim Biophys Acta, 1329, 321, 10.1016/S0005-2736(97)00125-9